| Page 101 | Kisaco Research

Early market entry is often necessary to generate revenue and support the commercialisation of innovation. Jasdeep Singh, CEO of SingleTimeMicroneedles, explains how his company bridged the financing gap through navigating alternatives to traditional regulatory and go-to-market strategies.

Milestone - Regulatory Approval
Biopharma
Treatment
Prevention
Go-to-Market
Companion and Livestock
2025 Showcase Finalist

Author:

Jasdeep Singh

CEO
SingleTimeMicroneedles

Jasdeep Singh

CEO
SingleTimeMicroneedles

Machine learning is reshaping discovery science in Human Health and Organicin Scientific is proving its potential in animal health too. Mat Mitchell, Co-Founder and CTO, shares how Organicin Scientific’s machine-learning platform automates candidate selection to identify, evaluate, and commercialise novel antimicrobials for safe and sustainable use across the industry.

Machine Learning
R&D
Drug Discovery
Antimicrobial
AI

Author:

Mathew Mitchell

Co-Founder and CTO
Organicin Scientific

Mathew Mitchell

Co-Founder and CTO
Organicin Scientific